Intelligent Bio Solutions Q1 FY27 net loss narrows 11% year-over-year to $2.67 million; Q1 revenue rises 25% year-over-year to $1.39 million

• Intelligent Bio Solutions’ fiscal first-quarter FY27 net loss narrowed 11% year-over-year to $2.67 million.
• Revenue climbed 25% year-over-year and 21% sequentially to a record $1.39 million.
• Gross profit margin reached 54.5%, reflecting manufacturing efficiencies and a higher share of higher-margin cartridge revenue.
• The company submitted its FDA 510(k) notification September 9, 2026, seeking clearance for its fingerprint drug-screening system to detect codeine.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611100830PRIMZONEFULLFEED9873778) on November 10, 2026, and is solely responsible for the information contained therein.